{
    "organizations": [],
    "uuid": "3e7c03310a531d89d5aa22197e4f534688a294b2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fda-revises-labeling-for-prescript/brief-fda-revises-labeling-for-prescription-opioid-cough-medicines-in-children-below-18-years-idUSFWN1P60VI",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Revises Labeling For Prescription Opioid Cough Medicines In Children Below 18 Years",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 11 (Reuters) - U.S. Food and Drug Administration:\n* U.S. FDA SAYS IS REQUIRING SAFETY LABELING CHANGES TO LIMIT USE OF PRESCRIPTION OPIOID COUGH MEDICINES WITH CODEINE/HYDROCODONE IN CHILDREN BELOW 18 YRS\n* ‍U.S. FDA SAYS LABELING FOR PRESCRIPTION OPIOID COUGH MEDICINES WITH CODEINE/HYDROCODONE BEING UPDATED FOR ADULT USE, INCLUDING EXPANDED BOXED WARNING‍​​ Source text: ( bit.ly/2Ex6nUe )\nOur Standards: The Thomson Reuters Trust Principles.",
    "published": "2018-01-12T01:48:00.000+02:00",
    "crawled": "2018-01-12T18:25:58.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "food",
        "drug",
        "administration",
        "fda",
        "say",
        "requiring",
        "safety",
        "labeling",
        "change",
        "limit",
        "use",
        "prescription",
        "opioid",
        "cough",
        "medicine",
        "child",
        "yr",
        "fda",
        "say",
        "labeling",
        "prescription",
        "opioid",
        "cough",
        "medicine",
        "updated",
        "adult",
        "use",
        "including",
        "expanded",
        "boxed",
        "source",
        "text",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}